Your browser doesn't support javascript.
loading
Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer.
Oh, Sung Yong; Lee, Suee; Huh, Seok Jae; Lee, Jeeyun; Kim, Seung Tae; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki; Kang, Byung Woog; Kim, Jong Gwang; Lee, Hyo Jin; Kim, Jung Hoon; Kang, Jung Hun; Kim, HoUng.
Affiliation
  • Oh SY; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.
  • Lee S; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.
  • Huh SJ; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lim HY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kang BW; Department of Oncology/Hematology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu, 41404, Republic of Korea.
  • Kim JG; Department of Oncology/Hematology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu, 41404, Republic of Korea. jkk21c@knu.ac.kr.
  • Lee HJ; Division of Hematology-Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
  • Kim JH; Division of Hematology/Oncology, Department of Internal Medicine, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
  • Kang JH; Division of Hematology/Oncology, Department of Internal Medicine, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
  • Kim H; CELLTRION Healthcare Co. Ltd, Incheon, Republic of Korea.
Cancer Chemother Pharmacol ; 83(3): 501-508, 2019 03.
Article in En | MEDLINE | ID: mdl-30535535
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Trastuzumab Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Cancer Chemother Pharmacol Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Trastuzumab Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Cancer Chemother Pharmacol Year: 2019 Document type: Article